Veronica Fuata, NP
Pediatrics · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Veronica Fuata’s office at (650) 721-6959 to ask if they take your plan before you enroll.
Medicaid work
$181,632 in 2024
Medicaid paid $181,632 for 1,298 billed services this clinician did in 2024, up to 79 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 498 | $181,063 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 111 | $376 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 13 | $192 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 15 | $0 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 30 | $0 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 27 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 38 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 15 | $0 |
| Application of topical fluoride | 25 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 28 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 38 | $0 |
| 2024 | 1,298 | 13 | 79 | $181,632 |
| 2023 | 1,535 | 9 | 77 | $218,044 |
| 2022 | 661 | 7 | 65 | $80,160 |
| 2021 | 1,975 | 11 | 79 | $222,630 |
| 2020 | 1,648 | 10 | 81 | $215,216 |
| 2019 | 1,524 | 14 | 78 | $204,170 |
| 2018 | 672 | 7 | 70 | $160,140 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 634 | $217,625 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 173 | $220 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year) | 39 | $198 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 17 | $0 |
| Application of topical fluoride | 18 | $0 |
| Short return visit (20+ min) | 28 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 63 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 24 | $0 |
| Service | 539 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 235 | $80,160 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 13 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 33 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 34 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 78 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 50 | $0 |
| Service | 218 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 680 | $222,630 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 41 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 74 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 24 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 37 | $0 |
| Short return visit (20+ min) | 190 | $0 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year) | 26 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 166 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 144 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 87 | $0 |
| Service | 506 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 655 | $215,123 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 17 | $51 |
| Short return visit (20+ min) | 297 | $42 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 13 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 13 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 39 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 14 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 121 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 62 | $0 |
| Service | 417 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 642 | $204,097 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 176 | $73 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 27 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 12 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 29 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 60 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 25 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 63 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 38 | $0 |
| Short return visit (20+ min) | 16 | $0 |
| Return visit (30+ min) | 13 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 56 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 494 | $160,140 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 25 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 12 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 24 | $0 |
| Return visit (30+ min) | 65 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 26 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 26 | $0 |
Drugs they prescribed that Part D paid
$322
Pharmacies billed $322 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 15) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
15 generic and 0 brand-name prescriptions · $322 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 15 | $322 | $21 |
Professional record
- NPI
- 1306231360
- Licence
- CA 95001667
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0200X (363LP0200X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2015-04-06
- NPI last updated
- 2015-04-06
This is when the NPI record was last certified, not a medical board exam.